Verastem Oncology

About:

Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.

Website: https://www.verastem.com

Twitter/X: VerastemOncolog

Top Investors: Hercules Capital, Bessemer Venture Partners, Biotechnology Value Fund, Longwood Fund, MPM Capital

Description:

Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.